In full transparency, the following is a press release submitted to SOURCE through its business wire service.
***
[broadstreet zone=”59948″]
NATICK – Pillar Biosciences, an innovative, next-generation sequencing (NGS) solutions, in-vitro diagnostics (IVD) company, today, announced that Randy Pritchard, Chief Executive Officer, will present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 16 at 12:30 p.m.
Pillar Biosciences is a global oncology solutions company delivering in-vitro diagnostics (IVD) that provide accurate, robust, timely, clinically actionable insights to guide treatment decisions throughout a patient’s continuum of care.
The Natick-based company powers the oncology ecosystem with our proprietary, automatable, NGS platform agnostic, SLIMamp® and PiVAT® technologies with a simplified workflow to expedite the delivery of robust and dependable clinical test results.
The Company’s mission is to enable access to high quality, affordable, specialty NGS testing, performed by any NGS laboratory as clinical grade tests, closer to home, for all patients.
Pillar has operations in Natick and in China.
[broadstreet zone=”59945″]
[broadstreet zone=”58610″]
The A Cappella Singers 
MetroWest Medical Center